灯盏花素注射液是临床常用中药注射液,其主要成分为灯盏细辛,内含黄酮、灯盏花乙素和灯盏花甲素等,具有活血化瘀,通脉止痛的功效,广泛用于脑供血不足、脑血栓、中风后遗症、冠心病、心绞痛等心脑血管疾病的治疗~([1])。近年来,随着临床应用的不断增多,其不良反应的报道也逐渐增加,为加强临床安全用药,规避用药风险,本研究总结我院使用灯盏花素注射液后64例患者出现不良反应的类型,现报道如下。1临床资料 Breviscapine Injection is commonly used in clinical medicine injection, the main components of Erigeron, containing flavonoids, Erigeron and Erigeron, etc., with blood circulation, Tongmai analgesic effect, widely used in cerebral blood supply Inadequate, cerebral thrombosis, stroke sequelae, coronary heart disease, angina and other cardiovascular and cerebrovascular diseases ~ ([1]). In recent years, with the increasing clinical application, the reports of adverse reactions are gradually increasing. In order to strengthen the clinical safety medication and avoid the risk of medication, this study summarizes the types of adverse reactions in 64 patients in our hospital after using breviscapine injection Now reported as follows. 1 clinical data